Zhao Ding
Vorstandsvorsitzender bei SICHUAN HUIYU PHARMACEUTICAL CO., LTD.
Vermögen: 226 Mio $ am 30.04.2024
Profil
Zhao Ding is the founder of Sichuan Huiyu Pharmaceutical Co., Ltd., where he holds the title of Chairman & General Manager since 2018.
He is also the founder of TYK Medicines, Inc., where he currently serves as a Non-Executive Director since 2024.
Dr. Ding obtained a doctorate degree from the University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.09.2023 | 114 066 766 ( 84,89% ) | 226 Mio $ | 30.04.2024 |
Aktive Positionen von Zhao Ding
| Unternehmen | Position | Beginn |
|---|---|---|
| SICHUAN HUIYU PHARMACEUTICAL CO., LTD. | Vorstandsvorsitzender | 12.10.2010 |
TYK Medicines, Inc.
 TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Direktor/Vorstandsmitglied | 01.01.2024 |
Ausbildung von Zhao Ding
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SICHUAN HUIYU PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
TYK Medicines, Inc.
TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Health Technology |
